Blog
Women's health

Off Protocol Episode 3: What’s ‘Normal’? The Hidden Burden of Heavy Menstrual Bleeding

Hosted by Lindus Health co-CEO Meri Beckwith, Off Protocol is the podcast that challenges the status quo of clinical trials. Each episode opens the door to honest conversations with experts across the industry — sharing real stories, confronting persistent challenges, and exploring what it takes to run trials that truly work for patients.

This episode focuses on an area of women’s health that has long been overlooked: heavy menstrual bleeding. Despite affecting millions of women worldwide, it remains underdiagnosed, undertreated, and under-researched.

Tune in, as guest host Zara Liew sits down with Dr. Michelle Griffin, women’s health expert advisor for Lindus Health, to explore why this evidence gap persists — and what it will take to close it. The conversation delves into what “normal” really means when it comes to menstruation, the challenges of studying menstrual health, and how thoughtful trial design, digital tools, and patient-centred approaches can finally bring this condition the clinical attention it deserves.

Listen on Spotify

Listen on Apple Podcasts

Listen on YouTube Podcasts

Listen on Amazon Music

This is some text inside of a div block.
This is some text inside of a div block.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Continue reading

More from Lindus

Lindus BG Image
01 Jul 2026
Blog

Three years in: what designing for clinicians taught me about trust

Three years into designing for clinical trials, every design choice serves one question: will a user trust this system enough to act through it, or will they hedge their bets with supplemental tools? Four principles have come to guide my answer to that question.

Lindus BG Image
03 Jun 2026
Articles

An AI pilot is only as good as the data pipeline underneath it: our response to the FDA on AI-enabled optimization of early-phase clinical trials

Lindus recently submitted a public comment to the FDA on the AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program (Docket No. FDA-2026-N-4390). We support the pilot and believe it can be designed to answer harder questions than the request for information currently sets up. 

Lindus BG Image
01 Jun 2026
Blog

Stop prototyping, start building: How AI is shaping product & design in 2026

At Lindus, we believe AI will empower our tech organization to build better products. LLMs are unlocking potential across product management, design, and engineering, in ways that would have seemed far-fetched even two years ago. But the way we work is changing fast, and we think it's worth sharing what that looks like in practice.

Lindus BG Image
20 May 2026
Blog

What James Lind would ask us on Clinical Trials Day

What James Lind would ask us on Clinical Trials Day is whether the systems we have built are worthy of the participants, sites, investigators, and teams who make clinical research possible.We do not think they are yet, but we know they can be.